Apiyasawat Sirin, Thomas Anish J, Spodick David H
Department of Medicine, Worcester Medical Center, and Division of Cardiovascular Medicine, University of Massachusetts Medical Center, Worcester, MA 01655, USA.
J Electrocardiol. 2005 Oct;38(4 Suppl):150-3. doi: 10.1016/j.jelectrocard.2005.06.027.
Interatrial block (IAB; P-wave duration, >or=120 milliseconds) is associated with increases of left atrial pressure. We studied the use of IAB during exercise tolerance test (ETT) in diagnosis of ischemic heart disease.
Exercise tolerance tests were performed in 149 patients (mean age, 50 years; male, 60.4%). P-wave duration was measured at rest, at each stage of exercise using the Bruce protocol, and in recovery. As clinically indicated, 71 patients subsequently underwent nuclear stress test and/or catheterization. The evidence of ischemia (EOI) was considered present according to the more definite test, that is, catheterization over nuclear stress test over ETT.
Among patients who did not have IAB at rest (n=115), 63 patients (54.7%) developed IAB during the ETT. The incidence of IAB during the ETT was higher in patients with EOI than patients without EOI (88.9% vs 51.9%, P=.03). When IAB during the ETT and positive ETT were used together to detect EOI, they were more accurate (86.1% vs 81.7%) than the ETT alone. Among patients with IAB at rest (n=34), patients with EOI had a higher incidence of P-wave duration increase of more than 20 milliseconds during the recovery period than patients without EOI (100% vs 21.8%, P=.015). When using P-wave duration increase of more than 20 milliseconds during the recovery period in conjunction with positive ETT, the sensitivity in detecting EOI was higher than using the ETT alone (100% vs 0%), but the specificity was worsened (68.8% vs 84.4%).
New IAB and worsening of IAB during ETT appeared in patients with ischemic heart disease and may be used as additional parameters for the ETT interpretation.
心房传导阻滞(IAB;P波时限≥120毫秒)与左心房压力升高有关。我们研究了运动耐量试验(ETT)期间IAB在缺血性心脏病诊断中的应用。
对149例患者(平均年龄50岁;男性占60.4%)进行运动耐量试验。在静息状态、使用布鲁斯方案的运动各阶段以及恢复阶段测量P波时限。根据临床指征,71例患者随后接受了核素负荷试验和/或心导管检查。根据更明确的检查结果,即心导管检查优于核素负荷试验优于ETT,判断是否存在缺血证据(EOI)。
在静息时无IAB的患者(n = 115)中,63例患者(54.7%)在ETT期间出现IAB。有EOI的患者在ETT期间IAB的发生率高于无EOI的患者(88.9%对51.9%,P = 0.03)。当将ETT期间的IAB和阳性ETT联合用于检测EOI时,它们比单独使用ETT更准确(86.1%对81.7%)。在静息时有IAB的患者(n = 34)中,有EOI的患者在恢复期P波时限增加超过20毫秒的发生率高于无EOI的患者(100%对21.8%,P = 0.015)。当将恢复期P波时限增加超过20毫秒与阳性ETT联合使用时,检测EOI的敏感性高于单独使用ETT(100%对0%),但特异性变差(68.8%对84.4%)。
缺血性心脏病患者在ETT期间出现新的IAB和IAB加重情况,可作为解释ETT结果的附加参数。